BC
| |
BML Capital Management, LLC13F | |
| BML Capital Management, LLC | |
| Last update 2025-02-07 | 25 Stocks (4 new) |
| Value $161.00 Mil | Turnover 14 % |
BML Capital Management, LLC Top Holdings of 2024-12-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACRS | Aclaris Therapeutics Inc | 14,250,000 | 35,340.0 | 0% | 21.950 | 0% | 13.320 | -51.11% | -19.76% | 213.0 | Medical Diagnostics & Research | |
SGOV | iShares 0-3 Month Treasury Bond ETF | 260,000 | 26,083.2 | -3.70% | 16.200 | -0.59% | 0.080 | -0.03% | +0.33% | 35,152.3 | ||
AVIR | Atea Pharmaceuticals Inc | 7,608,312 | 25,487.8 | +14.41% | 15.830 | +1.99% | 9.010 | -11.26% | -9.40% | 255.9 | Biotechnology | |
ADVM | Adverum Biotechnologies Inc | 2,268,064 | 10,591.9 | 0% | 6.580 | 0% | 10.900 | -29.67% | 0% | 98.0 | Biotechnology | |
ANTX | AN2 Therapeutics Inc | 5,749,432 | 7,934.2 | 0% | 4.930 | 0% | 19.240 | -32.34% | -18.12% | 33.9 | Biotechnology | |
TIL | Instil Bio Inc | 400,000 | 7,636.0 | +19.40% | 4.740 | +0.77% | 6.130 | -25.68% | +4.77% | 132.0 | Biotechnology | |
EPIX | ESSA Pharma Inc | 4,221,546 | 7,556.6 | New Holding | 4.690 | +4.69% | 9.510 | -6.15% | -6.15% | 74.1 | Biotechnology | |
AADI | Aadi Bioscience Inc | 2,100,000 | 6,625.5 | +5.00% | 4.120 | +0.20% | 8.500 | +9.83% | -18.54% | 63.2 | Biotechnology | |
ORMP | Oramed Pharmaceuticals Inc | 2,643,907 | 6,398.3 | +20.94% | 3.970 | +0.69% | 6.560 | -12.24% | -14.05% | 84.3 | Biotechnology | |
IKNA | Ikena Oncology Inc | 3,585,866 | 5,880.8 | +395.77% | 3.650 | +2.91% | 7.430 | -22.54% | -18.29% | 64.7 | Biotechnology |
BML Capital Management, LLC's Historical Top Holdings Breakdowns
BML Capital Management, LLC's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
BIL | SPDR Bloomberg 1-3 Month T-Bill ETF | 2024-12-31 | Sold Out | -9.45% | 91.29 ($91.59) 91.8 | $91.72 | 0.14% | Sold Out | 0 | -175,000 | |
EPIX | ESSA Pharma Inc | 2024-12-31 | New Buy | +4.69% | 1.4 ($3.14) 6.23 | $1.67 | -46.82% | New holding | 4,221,546 | 4,221,546 | |
TECX | Tectonic Therapeutic Inc | 2024-12-31 | Sold Out | -3.78% | 29.68 ($42.52) 51.7 | $25.29 | -40.51% | Sold Out | 0 | -211,752 | |
RPHM | Reneo Pharmaceuticals Inc | 2024-12-31 | Sold Out | -3.46% | 16.5 ($17.33) 18.2 | $18.20 | 5.02% | Sold Out | 0 | -345,740 | |
IKNA | Ikena Oncology Inc | 2024-12-31 | Add | +2.91% | 1.53 ($1.68) 1.76 | $1.34 | -20.24% | Add 395.77% | 3,585,866 | 2,862,578 | |
AVIR | Atea Pharmaceuticals Inc | 2024-12-31 | Add | +1.99% | 2.93 ($3.32) 3.82 | $3.03 | -8.73% | Add 14.41% | 7,608,312 | 958,312 | |
PMVP | PMV Pharmaceuticals Inc | 2024-12-31 | Add | +1.67% | 1.47 ($1.59) 1.78 | $1.37 | -13.84% | Add 105.28% | 3,466,684 | 1,777,912 | |
ATHA | Athira Pharma Inc | 2024-12-31 | New Buy | +1.01% | 0.42 ($0.57) 0.8 | $0.40 | -30.60% | New holding | 2,775,885 | 2,775,885 | |
TIL | Instil Bio Inc | 2024-12-31 | Add | +0.77% | 18.99 ($30) 58 | $20.23 | -32.57% | Add 19.4% | 400,000 | 65,000 | |
LENZ | LENZ Therapeutics Inc | 2024-12-31 | Reduce | -0.71% | 22.48 ($30.6) 37.37 | $21.80 | -28.76% | Reduce -84.55% | 9,271 | -50,729 |
BML Capital Management, LLC Total Holding History ($B)
BML Capital Management, LLC's Asset Allocation
BML Capital Management, LLC Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
BML Capital Management, LLC's Hypothetical Growth since 2024-12-31
BML Capital Management, LLC's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
BML Capital Management, LLC's Holdings Heat Map
Size field:
BML Capital Management, LLC's Holdings Bubble Chart
BML Capital Management, LLC News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers